Geldenhuys Werner J, Hanif Ahmad, Yun June, Nayeem Mohammed A
Department of Pharmaceutical Sciences, West Virginia University, School of Pharmacy, Morgantown, WV 26506, USA.
Department of Integrative Medical Sciences, Northeast Ohio Medical University College of Medicine, Rootstown, OH 44272, USA.
Molecules. 2017 Jun 1;22(6):917. doi: 10.3390/molecules22060917.
Cardiovascular diseases remain the number one diseases affecting patients' morbidity and mortality. The adenosine receptors are G-protein coupled receptors which have been of interest for drugs target for the treatment of multiple diseases ranging from cardiovascular to neurological. Adenosine receptors have been connected to several biological pathways affecting the physiology and pathology of the cardiovascular system. In this review, we will cover the different adenosine receptor ligands that have been identified to interact with adenosine receptors and affect the vascular system. These ligands will be evaluated from clinical as well as medicinal chemistry perspectives with more emphasis on how structural changes in structure translate into ligand potency and efficacy. Adenosine receptors represent a novel therapeutic target for development of treatment options treating a wide variety of diseases, including vascular disease and obesity.
心血管疾病仍然是影响患者发病率和死亡率的首要疾病。腺苷受体是G蛋白偶联受体,一直是治疗从心血管到神经等多种疾病的药物靶点。腺苷受体已与影响心血管系统生理和病理的多种生物学途径相关联。在本综述中,我们将涵盖已确定与腺苷受体相互作用并影响血管系统的不同腺苷受体配体。这些配体将从临床和药物化学角度进行评估,更侧重于结构变化如何转化为配体的效力和功效。腺苷受体是开发治疗多种疾病(包括血管疾病和肥胖症)治疗方案的新治疗靶点。